rewirebio.iobenchmarks
Dataset

AssayBench post-cutoff cohort of human CRISPR screens

The post-cutoff cohort of the AssayBench temporal split.

Research readiness

These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.

Release 2026-10-10-7fcc3e48a123 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • metric replay: verification is missing

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • metric replay: verification is missing
  • annotations: verification is missing
  • dependence: verification is missing

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • recipe pinned: verification is missing
  • resource estimate: verification is missing

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • independent validation: verification is missing
  • overlap checked: verification is missing

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Read reviewed discrepancy investigations

Evaluation results

16 evaluations · 48 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Biomni A1 (Claude 4) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.0728 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Biomni A1 (Claude 4) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Biomni A1 (Claude 4)' cohort 'LaTest', column 'AnDCG@100'
Configuration: Biomni A1 (Claude 4) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
NA directional-false-discovery-rate-at-100
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Biomni A1 (Claude 4) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Biomni A1 (Claude 4)' cohort 'LaTest', column 'dFDR@100'
Configuration: Biomni A1 (Claude 4) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.0214 precision-at-100
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Biomni A1 (Claude 4) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Biomni A1 (Claude 4)' cohort 'LaTest', column 'Precision@100'
Configuration: C2S (Gemma-2B) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.0078 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

C2S (Gemma-2B) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'C2S (Gemma-2B)' cohort 'LaTest', column 'AnDCG@100'
Configuration: C2S (Gemma-2B) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
NA directional-false-discovery-rate-at-100
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

C2S (Gemma-2B) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'C2S (Gemma-2B)' cohort 'LaTest', column 'dFDR@100'
Configuration: C2S (Gemma-2B) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.0784 precision-at-100
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

C2S (Gemma-2B) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'C2S (Gemma-2B)' cohort 'LaTest', column 'Precision@100'
Configuration: Embedding kNN (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.0271 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Embedding kNN on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Embedding kNN' cohort 'LaTest', column 'AnDCG@100'
Configuration: Embedding kNN (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
NA directional-false-discovery-rate-at-100
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Embedding kNN on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Embedding kNN' cohort 'LaTest', column 'dFDR@100'
Configuration: Embedding kNN (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.113 precision-at-100
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Embedding kNN on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Embedding kNN' cohort 'LaTest', column 'Precision@100'
Configuration: Gemini 3 Flash (GEPA) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.14 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Gemini 3 Flash (GEPA) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Flash (GEPA)' cohort 'LaTest', column 'AnDCG@100'
Configuration: Gemini 3 Flash (GEPA) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
NA directional-false-discovery-rate-at-100
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Gemini 3 Flash (GEPA) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Flash (GEPA)' cohort 'LaTest', column 'dFDR@100'
Configuration: Gemini 3 Flash (GEPA) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.307 precision-at-100
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Gemini 3 Flash (GEPA) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Flash (GEPA)' cohort 'LaTest', column 'Precision@100'
Configuration: Gemini 3 Flash (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.0908 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Flash on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Flash' cohort 'LaTest', column 'AnDCG@100'
Configuration: Gemini 3 Flash (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
NA directional-false-discovery-rate-at-100
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Flash on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Flash' cohort 'LaTest', column 'dFDR@100'
Configuration: Gemini 3 Flash (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.235 precision-at-100
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Flash on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Flash' cohort 'LaTest', column 'Precision@100'
Configuration: Gemini 3 Pro (Few-shot) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.13 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Pro (Few-shot) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Pro (Few-shot)' cohort 'LaTest', column 'AnDCG@100'
Configuration: Gemini 3 Pro (Few-shot) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
NA directional-false-discovery-rate-at-100
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Pro (Few-shot) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Pro (Few-shot)' cohort 'LaTest', column 'dFDR@100'
Configuration: Gemini 3 Pro (Few-shot) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.245 precision-at-100
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Pro (Few-shot) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Pro (Few-shot)' cohort 'LaTest', column 'Precision@100'
Configuration: Gemini 3 Pro (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.111 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Pro on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Pro' cohort 'LaTest', column 'AnDCG@100'
Configuration: Gemini 3 Pro (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
NA directional-false-discovery-rate-at-100
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Pro on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Pro' cohort 'LaTest', column 'dFDR@100'
Configuration: Gemini 3 Pro (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.234 precision-at-100
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Gemini 3 Pro on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gemini 3 Pro' cohort 'LaTest', column 'Precision@100'
Configuration: Gene-frequency (by phenotype) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.0888 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Gene-frequency (by phenotype) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gene-frequency (by phenotype)' cohort 'LaTest', column 'AnDCG@100'
Configuration: Gene-frequency (by phenotype) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
NA directional-false-discovery-rate-at-100
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Gene-frequency (by phenotype) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gene-frequency (by phenotype)' cohort 'LaTest', column 'dFDR@100'
Configuration: Gene-frequency (by phenotype) (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.187 precision-at-100
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Gene-frequency (by phenotype) on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gene-frequency (by phenotype)' cohort 'LaTest', column 'Precision@100'
Configuration: Gene-relevance predictor (AssayBench)Protocol: AssayBench: rank 100 candidate genes for a described CRISPR screen
Dataset: AssayBench post-cutoff cohort of human CRISPR screens
0.066 adjusted-ndcg-at-100
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Gene-relevance predictor on the AssayBench post-cutoff cohort

tgtval-20261009-protocol-debrouwer2026-screen-gene-ranking

Aggregation: Not reported

AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents · Table 3, row 'Gene-relevance predictor' cohort 'LaTest', column 'AnDCG@100'

Source checking is not independent reproduction. Release 2026-10-10-7fcc3e48a123.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

7 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-10-7fcc3e48a123
Property and statementOriginal source and locationReview and provenance
attributes.assay
Pooled human CRISPR screens with the screen's own significance criterion
Context-only references
AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents

Original source ↗

Sections 2.1 to 2.3; Table 1 (split statistics)

Version: arXiv:2605.10876 version 1, posted 2026-05-11; not peer reviewed
Retrieved: 2026-10-09T20:56:07Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 805b402c28e0daa186415af202e04df56bf0cd7c7b1f872a6db170ee3c6c623d

Hash scope: pdftotext -layout text layer, parsed by extract/extract_target_validation.py

Inspected artifact

attributes.population
19 benchmark entries from publications after September 2025, absent from BioGRID
Context-only references
AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents

Original source ↗

Sections 2.1 to 2.3; Table 1 (split statistics)

Version: arXiv:2605.10876 version 1, posted 2026-05-11; not peer reviewed
Retrieved: 2026-10-09T20:56:07Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 805b402c28e0daa186415af202e04df56bf0cd7c7b1f872a6db170ee3c6c623d

Hash scope: pdftotext -layout text layer, parsed by extract/extract_target_validation.py

Inspected artifact

attributes.scope_note
Each entry is one screen cast as a gene-ranking task. Hits are the genes meeting that screen's significance criterion; non-hits are assayed genes that do not meet it and are given relevance 0; for AnDCG@100, genes the screen did not assay are removed from the ranked list rather than counted as false positives; the printed Precision@100 and dFDR@100 formulas do not state that step. In screens with a bidirectional criterion, genes significant in the opposite direction get negative relevance.
Context-only references
AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents

Original source ↗

Sections 2.1 to 2.3; Table 1 (split statistics)

Version: arXiv:2605.10876 version 1, posted 2026-05-11; not peer reviewed
Retrieved: 2026-10-09T20:56:07Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 805b402c28e0daa186415af202e04df56bf0cd7c7b1f872a6db170ee3c6c623d

Hash scope: pdftotext -layout text layer, parsed by extract/extract_target_validation.py

Inspected artifact

attributes.source_locator
Sections 2.1 to 2.3; Table 1 (split statistics)
Context-only references
AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents

Original source ↗

Sections 2.1 to 2.3; Table 1 (split statistics)

Version: arXiv:2605.10876 version 1, posted 2026-05-11; not peer reviewed
Retrieved: 2026-10-09T20:56:07Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 805b402c28e0daa186415af202e04df56bf0cd7c7b1f872a6db170ee3c6c623d

Hash scope: pdftotext -layout text layer, parsed by extract/extract_target_validation.py

Inspected artifact

attributes.version
AssayBench, arXiv:2605.10876v1; built from the 2025 BioGRID ORCS release and 19 recent publications
Context-only references
AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents

Original source ↗

Sections 2.1 to 2.3; Table 1 (split statistics)

Version: arXiv:2605.10876 version 1, posted 2026-05-11; not peer reviewed
Retrieved: 2026-10-09T20:56:07Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 805b402c28e0daa186415af202e04df56bf0cd7c7b1f872a6db170ee3c6c623d

Hash scope: pdftotext -layout text layer, parsed by extract/extract_target_validation.py

Inspected artifact

description
The post-cutoff cohort of the AssayBench temporal split.
Context-only references
AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents

Original source ↗

Sections 2.1 to 2.3; Table 1 (split statistics)

Version: arXiv:2605.10876 version 1, posted 2026-05-11; not peer reviewed
Retrieved: 2026-10-09T20:56:07Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 805b402c28e0daa186415af202e04df56bf0cd7c7b1f872a6db170ee3c6c623d

Hash scope: pdftotext -layout text layer, parsed by extract/extract_target_validation.py

Inspected artifact

name
AssayBench post-cutoff cohort of human CRISPR screens
Context-only references
AssayBench: An Assay-Level Virtual Cell Benchmark for LLMs and Agents

Original source ↗

Sections 2.1 to 2.3; Table 1 (split statistics)

Version: arXiv:2605.10876 version 1, posted 2026-05-11; not peer reviewed
Retrieved: 2026-10-09T20:56:07Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 805b402c28e0daa186415af202e04df56bf0cd7c7b1f872a6db170ee3c6c623d

Hash scope: pdftotext -layout text layer, parsed by extract/extract_target_validation.py

Inspected artifact

Sources and history

Release 2026-10-10-7fcc3e48a123 · Record review: source checked

1 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: tgtval-20261009-data-assaybench-post-cutoff

areas
cells-tissues
contexts
research
version
AssayBench, arXiv:2605.10876v1; built from the 2025 BioGRID ORCS release and 19 recent publications
population
19 benchmark entries from publications after September 2025, absent from BioGRID
assay
Pooled human CRISPR screens with the screen's own significance criterion
scope note
Each entry is one screen cast as a gene-ranking task. Hits are the genes meeting that screen's significance criterion; non-hits are assayed genes that do not meet it and are given relevance 0; for AnDCG@100, genes the screen did not assay are removed from the ranked list rather than counted as false positives; the printed Precision@100 and dFDR@100 formulas do not state that step. In screens with a bidirectional criterion, genes significant in the opposite direction get negative relevance.
source locator
Sections 2.1 to 2.3; Table 1 (split statistics)
missing metadata
positives: reason: unreported; note: Hit counts per entry are not printed; relevance is a per-screen percentile construction
Related records

Suggest a correction